Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Bronchoscopic EmphysemA Treatment in THE NetherLands

Bronchoscopic Lung Volume Reduction Treatment in Clinical Practice: Introduction and Implementation in The Netherlands and Evaluation of a National Database

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Rationale: New bronchoscopic treatments for emphysema have shown promise in clinical trials, improving lung function, exercise capacity and possibly survival and are now being adopted by a number of centres in the Netherlands. It is important to ensure that the benefits seen in clinical trials are in fact reflected in clinical practice and that the best use of this early 'real world' experience is made to optimise the development and use of these novel therapies. Overall objective: to develop a national database to record bronchoscopic lung volume reduction procedures for patients with emphysema. This is desirable for audit purposes but will also be an important resource for research both in gathering data and in facilitating collaborations.

Who May Be Eligible (Plain English)

Who May Qualify: - Patient is scheduled for a bronchoscopic lung volume treatment using one-way valves. Who Should NOT Join This Trial: - There are no exclusion criteria for this study. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patient is scheduled for a bronchoscopic lung volume treatment using one-way valves. Exclusion Criteria: * There are no exclusion criteria for this study.

Locations (2)

University Medical Center Groningen
Groningen, Netherlands
Maastricht University Medical Center
Maastricht, Netherlands